Literature DB >> 30556355

Inhibition of Pseudomonas aeruginosa and Mycobacterium tuberculosis disulfide bond forming enzymes.

Cristina Landeta1, Laura McPartland1, Ngoc Q Tran1, Brian M Meehan1, Yifan Zhang1, Zaidi Tanweer2, Shoko Wakabayashi3, Jeremy Rock3, Taehyun Kim1, Deepak Balasubramanian1, Rebecca Audette3, Melody Toosky3, Jessica Pinkham3, Eric J Rubin3, Stephen Lory1, Gerald Pier2, Dana Boyd1, Jon Beckwith1.   

Abstract

In bacteria, disulfide bonds confer stability on many proteins exported to the cell envelope or beyond, including bacterial virulence factors. Thus, proteins involved in disulfide bond formation represent good targets for the development of inhibitors that can act as antibiotics or anti-virulence agents, resulting in the simultaneous inactivation of several types of virulence factors. Here, we present evidence that the disulfide bond forming enzymes, DsbB and VKOR, are required for Pseudomonas aeruginosa pathogenicity and Mycobacterium tuberculosis survival respectively. We also report the results of a HTS of 216,767 compounds tested against P. aeruginosa DsbB1 and M. tuberculosis VKOR using Escherichia coli cells. Since both P. aeruginosa DsbB1 and M. tuberculosis VKOR complement an E. coli dsbB knockout, we screened simultaneously for inhibitors of each complemented E. coli strain expressing a disulfide-bond sensitive β-galactosidase reported previously. The properties of several inhibitors obtained from these screens suggest they are a starting point for chemical modifications with potential for future antibacterial development.
© 2018 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30556355      PMCID: PMC6458069          DOI: 10.1111/mmi.14185

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  46 in total

Review 1.  Establishment of Pseudomonas aeruginosa infection: lessons from a versatile opportunist.

Authors:  J B Lyczak; C L Cannon; G B Pier
Journal:  Microbes Infect       Date:  2000-07       Impact factor: 2.700

2.  Bacterial species exhibit diversity in their mechanisms and capacity for protein disulfide bond formation.

Authors:  Rachel J Dutton; Dana Boyd; Mehmet Berkmen; Jon Beckwith
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-11       Impact factor: 11.205

Review 3.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

4.  Broad-host-range expression vectors that carry the L-arabinose-inducible Escherichia coli araBAD promoter and the araC regulator.

Authors:  J R Newman; C Fuqua
Journal:  Gene       Date:  1999-02-18       Impact factor: 3.688

5.  Inhibition of virulence-promoting disulfide bond formation enzyme DsbB is blocked by mutating residues in two distinct regions.

Authors:  Cristina Landeta; Brian M Meehan; Laura McPartland; Linda Ingendahl; Feras Hatahet; Ngoc Q Tran; Dana Boyd; Jon Beckwith
Journal:  J Biol Chem       Date:  2017-02-23       Impact factor: 5.157

Review 6.  Animal models of human pneumonia.

Authors:  Joseph P Mizgerd; Shawn J Skerrett
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-12-27       Impact factor: 5.464

7.  DsbL and DsbI contribute to periplasmic disulfide bond formation in Salmonella enterica serovar Typhimurium.

Authors:  Dongxia Lin; Byoungkwan Kim; James M Slauch
Journal:  Microbiology (Reading)       Date:  2009-10-01       Impact factor: 2.777

Review 8.  Vitamin K2 in electron transport system: are enzymes involved in vitamin K2 biosynthesis promising drug targets?

Authors:  Michio Kurosu; Eeshwaraiah Begari
Journal:  Molecules       Date:  2010-03-10       Impact factor: 4.411

Review 9.  Antimycobacterial Metabolism: Illuminating Mycobacterium tuberculosis Biology and Drug Discovery.

Authors:  Divya Awasthi; Joel S Freundlich
Journal:  Trends Microbiol       Date:  2017-06-13       Impact factor: 17.079

10.  Dissecting the machinery that introduces disulfide bonds in Pseudomonas aeruginosa.

Authors:  Isabelle S Arts; Geneviève Ball; Pauline Leverrier; Steven Garvis; Valérie Nicolaes; Didier Vertommen; Bérengère Ize; Veronica Tamu Dufe; Joris Messens; Romé Voulhoux; Jean-François Collet
Journal:  mBio       Date:  2013-12-10       Impact factor: 7.867

View more
  9 in total

Review 1.  CRISPR-Based Approaches for Gene Regulation in Non-Model Bacteria.

Authors:  Stephanie N Call; Lauren B Andrews
Journal:  Front Genome Ed       Date:  2022-06-23

2.  Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.

Authors:  R Christopher D Furniss; Nikol Kaderabkova; Declan Barker; Patricia Bernal; Evgenia Maslova; Amanda A A Antwi; Helen E McNeil; Hannah L Pugh; Laurent Dortet; Jessica M A Blair; Gerald Larrouy-Maumus; Ronan R McCarthy; Diego Gonzalez; Despoina A I Mavridou
Journal:  Elife       Date:  2022-01-13       Impact factor: 8.713

Review 3.  The 27th Annual Midwest Microbial Pathogenesis Conference in the Age of COVID.

Authors:  Neal D Hammer; Christopher M Waters
Journal:  J Bacteriol       Date:  2022-05-04       Impact factor: 3.476

Review 4.  Protein Disulfide Exchange by the Intramembrane Enzymes DsbB, DsbD, and CcdA.

Authors:  John H Bushweller
Journal:  J Mol Biol       Date:  2020-04-16       Impact factor: 5.469

Review 5.  Union Is Strength: Target-Based and Whole-Cell High-Throughput Screens in Antibacterial Discovery.

Authors:  Cristina Landeta; Adrian Mejia-Santana
Journal:  J Bacteriol       Date:  2021-11-01       Impact factor: 3.476

6.  The Vibrio cholerae Quorum-Sensing Protein VqmA Integrates Cell Density, Environmental, and Host-Derived Cues into the Control of Virulence.

Authors:  Ameya A Mashruwala; Bonnie L Bassler
Journal:  mBio       Date:  2020-07-28       Impact factor: 7.867

Review 7.  Handling the Hurdles on the Way to Anti-tuberculosis Drug Development.

Authors:  Pedro F Dalberto; Eduardo V de Souza; Bruno L Abbadi; Christiano E Neves; Raoní S Rambo; Alessandro S Ramos; Fernanda S Macchi; Pablo Machado; Cristiano V Bizarro; Luiz A Basso
Journal:  Front Chem       Date:  2020-11-19       Impact factor: 5.221

8.  A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics.

Authors:  Anthony D Verderosa; Rabeb Dhouib; Yaoqin Hong; Taylah K Anderson; Begoña Heras; Makrina Totsika
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

Review 9.  Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.

Authors:  Paula Roszczenko-Jasińska; Marta Ilona Wojtyś; Elżbieta K Jagusztyn-Krynicka
Journal:  Appl Microbiol Biotechnol       Date:  2020-10-14       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.